In a groundbreaking advancement for cardiac care, the world’s smallest pacemaker is set to transform treatment for bradycardia, a condition marked by an abnormally slow heart rate. Traditionally, patients with bradycardia required a bulky, battery-powered pacemaker implanted through a chest incision. This method involves risks such as bleeding, infection, and lead malfunction, with approximately 12% of patients experiencing complications.
The new leadless pacemaker, the size of a vitamin capsule, represents a significant leap forward. Implanted directly into the heart via a vein in the leg, this device eliminates the need for wires and external leads, reducing the procedure’s invasiveness and scarring. Dr. A.M. Karthigesan, Senior Consultant Cardiologist & Electrophysiologist at Apollo Hospitals, Chennai, highlights the benefits: “The leadless pacemaker offers a less invasive alternative, with a procedure time much shorter than traditional methods, allowing many patients to return home the same day.”
In Kolkata, this innovative technology is poised to make a notable impact. The city’s healthcare market is increasingly adopting advanced medical technologies, with hospitals poised to integrate leadless pacemakers to enhance patient outcomes. As this new technology becomes more accessible, it promises to reduce hospital stays and associated costs, reflecting a broader trend towards minimizing surgical risks and optimizing recovery times. With a high implant success rate of 99.1%, the leadless pacemaker is particularly advantageous for elderly patients and those with multiple health issues.
